Literature DB >> 29132815

Impaired mismatch negativity to frequency deviants in individuals at ultra-high risk for psychosis, and preliminary evidence for further impairment with transition to psychosis.

Suzie Lavoie1, Bradley N Jack2, Oren Griffiths2, Ayaka Ando3, Paul Amminger3, Anthony Couroupis3, Aidan Jago3, Connie Markulev3, Patrick D McGorry3, Barnaby Nelson3, Andrea Polari4, Hok Pan Yuen3, Thomas J Whitford2.   

Abstract

BACKGROUND: There is evidence to suggest that people with established psychotic disorders show impairments in the mismatch negativity induced by a frequency-deviant sound (fMMN), and that these impairments worsen with the deterioration of psychotic symptoms. This study aimed to test whether individuals at ultra-high risk (UHR) for psychosis show pre-morbid impairments in fMMN, and if so, whether fMMN continues to deteriorate with transition to psychosis.
METHOD: fMMN was recorded in a cohort of UHR individuals (n=42) and compared to healthy controls (n=29). Of the 27 UHR participants who returned for a second EEG session, six participants had transitioned to psychosis by 12-month follow-up (UHR-T) and were compared to the 21 participants who did not transition (UHR-NT).
RESULTS: fMMN amplitude was significantly reduced, relative to healthy controls, in the UHR cohort. Furthermore, UHR-T individuals showed a significant decrease in fMMN amplitude over the period from baseline to post-transition; this reduction was not observed in UHR-NT.
CONCLUSIONS: These results suggest that fMMN is abnormal in UHR individuals, as has repeatedly been found previously in people with established psychotic disorders. The finding that fMMN impairment worsens with transition to psychosis is consistent with the staging model of psychosis; however, caution must be taken in interpreting these findings, given the extremely small sample size of the UHR-T group.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Event-related potential (ERP); Mismatch negativity (MMN); Psychosis; Transition; Ultra high risk (UHR)

Mesh:

Year:  2017        PMID: 29132815     DOI: 10.1016/j.schres.2017.11.005

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  8 in total

1.  Attenuated Mismatch Negativity in Attenuated Psychosis Syndrome Predicts Psychosis: Can Galantamine-Memantine Combination Prevent Psychosis?

Authors:  Maju Mathew Koola
Journal:  Mol Neuropsychiatry       Date:  2018-06-07

2.  Decomposing the constituent oscillatory dynamics underlying mismatch negativity generation in schizophrenia: Distinct relationships to clinical and cognitive functioning.

Authors:  W C Hochberger; Y B Joshi; W Zhang; M L Thomas; D L Braff; N R Swerdlow; G A Light
Journal:  Int J Psychophysiol       Date:  2018-12-23       Impact factor: 2.997

Review 3.  Electroencephalography and Event-Related Potential Biomarkers in Individuals at Clinical High Risk for Psychosis.

Authors:  Holly K Hamilton; Alison K Boos; Daniel H Mathalon
Journal:  Biol Psychiatry       Date:  2020-04-14       Impact factor: 13.382

Review 4.  Potential Roles of Redox Dysregulation in the Development of Schizophrenia.

Authors:  Diana O Perkins; Clark D Jeffries; Kim Q Do
Journal:  Biol Psychiatry       Date:  2020-04-02       Impact factor: 13.382

5.  Abnormal development of early auditory processing in 22q11.2 Deletion Syndrome.

Authors:  Lucia-Manuela Cantonas; Miralena I Tomescu; Marjan Biria; Reem K Jan; Maude Schneider; Stephan Eliez; Tonia A Rihs; Christoph M Michel
Journal:  Transl Psychiatry       Date:  2019-04-16       Impact factor: 6.222

6.  The Relationship Between Affective Visual Mismatch Negativity and Interpersonal Difficulties Across Autism and Schizotypal Traits.

Authors:  Talitha C Ford; Laila E Hugrass; Bradley N Jack
Journal:  Front Hum Neurosci       Date:  2022-03-23       Impact factor: 3.169

7.  Duration Mismatch Negativity Predicts Remission in First-Episode Schizophrenia Patients.

Authors:  Suguru Nakajima; Yuko Higuchi; Takahiro Tateno; Daiki Sasabayashi; Yuko Mizukami; Shimako Nishiyama; Tsutomu Takahashi; Michio Suzuki
Journal:  Front Psychiatry       Date:  2021-11-25       Impact factor: 4.157

8.  MR-Spectroscopy of GABA and Glutamate/Glutamine Concentrations in Auditory Cortex in Clinical High-Risk for Psychosis Individuals.

Authors:  Tineke Grent-'t-Jong; Ruchika Gajwani; Joachim Gross; Andrew I Gumley; Stephen M Lawrie; Matthias Schwannauer; Frauke Schultze-Lutter; Stephen R Williams; Peter J Uhlhaas
Journal:  Front Psychiatry       Date:  2022-03-29       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.